Riskpilot← Back to searchSign inGet full accessScientieatiV AB
ABActiveOrg 5591943872Sjöstigen 20General medical practice activities · NACE 8621Est. 20191 employees
Revenue 2024
SEK 1,6M
+52% vs 2023
EBITDA margin
22.6%
-46% vs 2023
Equity ratio
13.8%
Financial strength
Net profit 2024
SEK 259K
-50% vs 2023
| Revenue | SEK 1,6M | +52% |
| EBITDA | SEK 371K | -46% |
| Net profit | SEK 259K | -50% |
| Total assets | SEK 694K | -13% |
| Equity | SEK 96K | -83% |
| Employees | 1 | — |
Legal name
ScientieatiV AB
Org number
5591943872
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 februari 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Sjukvård, friskvård samt handel med artiklar inom dessa områden. Organisationsutveckling. Handel med finansiella instrument. Produktion och renovering av hus, samt byggprojektledning. Uthyrning av maskiner. Fastighetsförvaltning.
Address
Sjöstigen 20
Email
scientieativ@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 196 | 250 | 279 | 1 081 | 1 642 |
| Staff expenses | — | — | −11 | −157 | −825 |
| EBITDA | 30 | 199 | 31 | 693 | 371 |
| Depreciation & amort. | −33 | −58 | −58 | −58 | −52 |
| EBIT | −3 | 141 | −27 | 635 | 319 |
| Net financials | −1 | — | −0 | 6 | 8 |
| Profit before tax | −4 | 141 | −27 | 641 | 327 |
| Tax | −0 | −30 | — | −127 | −69 |
| Net profit | −4 | 111 | −27 | 515 | 259 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 292 | 478 | 356 | 800 | 694 |
| Equity | 226 | 337 | 310 | 565 | 96 |
| Long-term debt | 0 | 0 | 15 | 0 | — |
| Short-term debt | 66 | 141 | 31 | 235 | 598 |
| Total debt | 66 | 141 | 46 | 235 | 598 |
EBITDA margin
22.6%
This company
15.8%
Market median
+43% vs market
20202024
Equity ratio
13.8%
This company
38.2%
Market median
-64% vs market
20202024
Return on equity
269.0%
This company
18.4%
Market median
+1362% vs market
20202024
Net profit margin
15.7%
This company
8.1%
Market median
+94% vs market
20202024
Asset turnover
2.37×
This company
1.12×
Market median
+112% vs market
20202024
Debt / equity
6.22×
This company
0.62×
Market median
-903% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ScientieatiV AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elin Linnea Svedlund Eriksson | Deputy Board Member | 0 companies |
| Joel Erik Sigar Eriksson | Board of Directors | 0 companies |